Tenaya Therapeutics (TNYA) announced the publications of positive preclinical data for TN-201, the company’s gene therapy candidate for ...

In a report released today, Edward Tenthoff from Piper Sandler maintained a Buy rating on Century Therapeutics (IPSC – Research Report), with a price target of $2.00. The company’s shares ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

"So, we're using direct conversion, where instead of going through an iPSC intermediate ... eight genes was delivered using a separate viral vector, making it difficult to ensure that each ...